News

From Alzheimer's Research to Aerosmith: Rudy Tanzi on Creativity in Science and Music

Posted: Jan. 14, 2014

For PBS's series "The Secret Life of Scientists and Engineers", Rudy Tanzi, Ph.D., talks about his life-long love of music.

Increasing Public Understanding of Alzheimer’s in Stuart, Florida

Posted: Jan. 10, 2014

Increasing public understanding of Alzheimer’s disease is the goal of two free screenings of “The Genius of Marian” (right), featured at the 2013 Tribeca Film Festival, and a presentation by leading Alzheimer’s researcher and chair of the Cure Alzheimer’s Fund Research Consortium, Rudy Tanzi, Ph.D. Both events are co-sponsored through Cure Alzheimer’s

Stem Cell Model of Familial Alzheimer's Identifies New AD Genes

Posted: Jan. 8, 2014

A stem cell model of familial Alzheimer’s disease (FAD) was successfully generated in a recent study, allowing researchers to identify 14 genes potentially implicated in the disease. One gene in particular demonstrates the important role inflammation may play in the brain of Alzheimer’s patients. The study was completed by scientists at The New York Stem Cell Foundation (NYSCF) Research Institute in collaboration with scientists at the Icahn School of Medicine at Mount Sinai (ISMMS) and funded in part by the Cure Alzheimer’s Fund (CAF).

Living Brain Cells Created from Biobanked Alzheimer's Brain Tissue

Posted: Jan. 8, 2014

Scientists at The New York Stem Cell Foundation (NYSCF) Research Institute, working in collaboration with scientists from Columbia University Medical Center (CUMC), for the first time generated induced pluripotent stem (iPS) cells lines from non-cryoprotected brain tissue of patients with Alzheimer’s disease.

Rudy Tanzi on CBS: How Close is a Treatment for Alzheimer's?

Posted: Jan. 6, 2014

On Saturday, January 4, Rudy Tanzi, Ph.D. appeared on CBS News' This Morning to discuss the current state of research towards an Alzheimer's cure.

In the segment, Tanzi explains some of the reasons behind past drug failures and the ways in which the current generation of drugs in development will hopefully avoid these pitfalls. He also describes preventative measures one can take against the disease, such as healthy diet, exercise, and social engagement.

Circadian Clock Proteins a Potential Therapeutic Target for Alzheimer’s

Posted: Dec. 19, 2013

Brain aging is associated with lower production of circadian clock proteins, which synchronize biological processes to light and dark cycles. In Alzheimer’s and other neurodegenerative diseases, circadian dysfunction is commonly observed.

Jeff Morby: The Answers Are Being Revealed

Posted: Nov. 21, 2013

Several weeks ago, the Cure Alzheimer’s Fund (CAF) Executive Committee and staff met with the members of our Research Consortium in Chicago.

Drs. Schadt and Huganir Join Research Consortium

Posted: Nov. 18, 2013

Adding to its impressive roster of many of the nation’s leading scientists, the Cure Alzheimer’s Fund Research Consortium is pleased to announce its two newest members, Eric Schadt, Ph.D. (left), and Rick Huganir, Ph.D. (right).

The Research Consortium develops and updates a “roadmap for research” for the most effective and efficient route to slowing, stopping and/or reversing Alzheimer’s disease, the most common form of dementia. Members research their own projects and recruit others whose work will hasten the development of effective therapies.

Senator Markey (D-MA) To Co-Chair Alzheimer's Task Force

Posted: Nov. 8, 2013

Washington (November 7, 2013) – As the country commemorates November as National Alzheimer’s Awareness month, Senator Edward J. Markey (D-Mass.) has been announced as the new Senate co-chair of the Bipartisan Congressional Task Force on Alzheimer’s Disease. Senator Markey was co-chair of the Task Force with Rep. Chris Smith (R-N.J.) when he served in the House of Representatives. While in the House, then-Rep. Markey co-authored the National Alzheimer’s Project Act, which mandated the development of a first-ever comprehensive National Plan to Address Alzheimer’s Disease.

Dr. Thomas Südhof Wins Nobel Prize

Posted: Oct. 7, 2013

Our congratulations to Dr. Thomas C. Sϋdhof of Stanford University, a member of Cure Alzheimer’s Fund's Research Consortium, who joins Randy Scheckman of the University of California, Berkeley and James E. Rothman of Yale University in winning the Nobel Prize in Physiology or Medicine as announced today.